| Revenue growth | 22% YoY |
|---|---|
| Margins | Gross margin expanded 74 bps YoY to 65.6%. |
| Demand visibility | Strong; US rank #1 in 10 products out of 35. |
| Management confidence | High; foundations translate into execution confidence and business resilience. |
Growth
Revenue grew 22% YoY to ₹14,768 Mn; EBITDA up 37% to ₹3,389 Mn; PAT jumped 60% to ₹1,800 Mn.
Outlook
Investing in R&D (6% of sales) for Complex Gx, digitalization, and modular growth projects at existing facilities.
Risks
External cost pressures and supply chain volatility noted for the next couple of quarters.
Last quarter's promises, checked
Delivered
- Guided sequential growth → delivered 6th consecutive quarter growth (= BEAT)
- Guided peptide CDMO EBITDA positive Q4 → delivered positive EBITDA in Q4 (= BEAT)
- Guided net debt reduction → delivered ₹4,021 Mn from ₹7,061 Mn (= BEAT)
Partly delivered
- Guided FY27 remediation spend lower → delivered Q1FY27 improvement but volatility remains (= PARTIAL)
Missed
- Guided Q4 capex ~₹1,298 Mn → delivered ₹1,000 Mn (= MISS)
Investor Presentation filed with NSE, NSE: GRANULES. Summary written with AI assistance from the document.
Granules India Ltd: key numbers
- Share price
- ₹868.65
- Market cap
- ₹21,525 Cr
- Revenue (annual)
- ₹5,366 Cr
- Net profit (annual)
- ₹595.0 Cr
- P/E (TTM)
- 32.5×Sector 50.4×
- Promoter holding
- 37.39%-0.63% QoQ
- FII holding
- 20.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Granules India Ltd
All →Granules India Promoter Buying
Promoter Uma Devi Chigurupati acquired 2.48 crore shares of Granules India Ltd via the open market. This transaction increases the promoter stake by 8.70%.
- Promoter stake change
- +8.70%
Granules India Other Announcement
The company submitted its quarterly shareholding pattern disclosure as required by SEBI regulations for the period ended September 16, 2026.
Granules India Capital Structure Change
Granules India allotted 2.49 crore equity shares to its promoter group upon warrant conversion, raising Rs. 1,461.50 Crore. This increases the company's total paid-up equity capital.
- Value
- ₹1,462 Cr
Granules India Capital Structure Change
Granules India received Rs. 1,093 crore from the Promoter group, representing the balance 75% subscription for the conversion of 2.49 crore warrants into equity shares.
- Value
- ₹1,093 Cr
Granules India Promoter Selling
Promoter Dr. Krishna Prasad Chigurupati sold 1.72 crore equity shares of Granules India Ltd via block deal and open market, reducing aggregate promoter stake.
- Promoter stake change
- -6.94%
Granules India Earnings Call Transcript: Key Takeaways
Granules India Q1 FY27 results show strong performance with Revenue growing 22% YoY and PAT up 60%, driven by a significant mix shift towards high-margin Complex Generics.